The global molecular diagnostics market is projected to reach USD 10.12 Billion by 2021 from USD 6.54 Billion in 2016, at a CAGR of 9.1% from 2016 to 2021. In this report, the global market is broadly segmented by products & services, application, technology, end user, and region. As most diagnostic tests are performed in-house, the hospital & academic laboratories segment is expected to dominate the market.
Access Report at www.rnrmarketresearch.com/contacts…mple?rname=186727 .
The molecular diagnostics market is broadly segmented on the basis of technology, applications, products & services, end user, and region. The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing, and Next-generation sequencing (NGS), and other technologies (electrophoresis, flow cytometry, and mass spectrometry).
- Manufacturers and distributors of molecular diagnostic instruments & assays
- In vitro diagnostic (IVD) companies
- Hospital laboratories
- Reference laboratories
- Pharmaceutical and biotechnology companies
- Research and consulting firms
- Health insurance players
Major factors driving molecular diagnostics market are high prevalence of infectious diseases & various types of cancer, increasing awareness and acceptance of personalized medicine & companion diagnostics, growth in biomarker identification market & advancements in molecular techniques; & reforms in reimbursement system in U.S.
Complex regulatory framework major factor restraining growth of market.
More Information at www.rnrmarketresearch.com/contacts…ying?rname=186727 .
Molecular diagnostics market segment will grow at the fastest pace during the forecast period. On basis of region, North America is expected to account for largest share of global molecular diagnostics market in 2016, followed by Europe.
Growth of North American molecular diagnostics market is majorly driven by the factors such as availability of government funds, growing applications of MDx in genetic disorders and cancer screening, and ease of use of self-monitoring techniques.
2 Molecular Diagnostics Market Share Analysis
3 Market Competitor Share Analysis, By Application
4 Market Share Analysis for Blood Screening Applications
5 Ranking for Microbiology Applications
6 Molecular Diagnostics Market Share Analysis, By Technology
7 Polymerase Chain Reaction (PCR)
8 DNA Sequencing and NGs
10 Hybridization (In Situ and Fluorescence)
11 Isothermal Nucleic Acid Amplification Technology (INAAT)
12 New Product Launches and Approvals
13 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts
The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and applications. Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V.
(Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid Inc.
Access report @ www.rnrmarketresearch.com/contacts…ount?rname=186727 .
Company profiles comprise basic views on key players in molecular diagnostics market & product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in near future.
Above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.